Statistics Canada is conducting a new cycle of the Canadian COVID-19 Antibody and Health Survey (CCAHS), in partnership with the Public Health Agency of Canada (PHAC) and the COVID-19 Immunity Task Force (CITF).
The COVID-19 situation continues to be highly dynamic and is changing daily. Public health actions are evolving as the situation is assessed with the information available.
A seasonal influenza vaccination is considered the most effective method to protect against the flu.
On October 16, 2017, the CSRT announced the board of director’s decision that the CSRT would refocus on strategic paths more closely tied to its mandate
Medavie Blue Cross is proud to announce our innovative new approach to managing chronic disease- the first program of its kind in the Canadian private health insurance industry. This Asthma and COPD module is the first in our new Managing Chronic Disease program, and we are proud to be partnering with the Canadian Lung Association to help develop this module.
Medavie Blue Cross announced today that patients diagnosed with asthma and/or chronic obstructive pulmonary disease (COPD) will be linked to enhanced services and supports that allow them to seek advice and guidance from respiratory therapists (RRTs) to effectively manage their symptoms. To be eligible for the plan RTs must have a CRE/CAE designation and have CSRT professional liability insurance. The Medavie Blue Cross reimbursement program will be launched in early spring 2015. Patients who suffer from asthma and/or COPD will be able to self-refer to an RRT.
The CSRT's provider of professional liability insurance (PLI) has developed a promotional video – this is a tool to promote the importance of PLI.
The NBART has recently released a position statement on the role of Respiratory Therapists in the medication reconciliation process.